مقالات

Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers

Hepat Mon. 2015 Dec 29;15(12):e35238

Authors

Rezaee-Zavareh MS1, Karimi-Sari H1, Dolatimehr F1, Alavian SM2

Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, Iran

Hepat Mon. 2015 Dec 27;15(12):e26407

Authors

Bagheri Lankarani K1, Homayon K2, Motevalli D1, Heidari ST1, Alavian SM3, Malek-Hosseini SA4

Evaluation of Iron Oxide Nanoparticles Toxicity on Liver Cells of BALB/c Rats

Iran Red Crescent Med J. 2016 Jan 30;18(1):e28939

Authors

Parivar K1, Malekvand Fard F1, Bayat M2, Alavian SM3, Motavaf M4

Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies

Hepat Mon. 2015 Nov 28;15(11):e33462

Authors

Rezaee Zavareh MS1, Alavian SM2

Iran, sanctions, and research collaborations

Lancet. 2016 Jan 2;387(10013):28-9

Authors

Rezaee-Zavareh MS1, Karimi-Sari H1, Alavian SM2

Occult HCV Infection: The Current State of Knowledge

Iran Red Crescent Med J. 2015 Nov 29;17(11):e34181

Authors

Rezaee-Zavareh MS1, Hadi R2, Karimi-Sari H3, Hossein Khosravi M3, Ajudani R3, Dolatimehr F3, Ramezani-Binabaj M3, Miri SM4, Alavian SM5

Hepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response

World J Gastroenterol. 2015 Dec 21;21(47):13225-39

Authors

Yeganeh B1, Rezaei Moghadam A1, Alizadeh J1, Wiechec E1, Alavian SM1, Hashemi M1, Geramizadeh B1, Samali A1, Bagheri Lankarani K1, Post M1, Peymani P1, Coombs KM1, Ghavami S1

Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces

Iran J Microbiol. 2015 Aug;7(4):214-20

Authors

Ramezani F1, Alavian SM2, Sadeghi A1, Khedive A1, Ghalichi L3, Norouzi M1, Karimzadeh H1, Malekzadeh R4, Montazeri G4, Nejatizadeh A5, Ziaee M6, Abedi F7, Ataei B8, Yaran M8, Sayad B9, Somi MH10, Sarizadeh G11, Sanei-Moghaddam I12, Mansour-Ghanaei F13, Rafatpanah H14, Keyvani H15, Kalantari E16, Saberfiroozi M17, Rezaee R18, Daram M1, Mahabadi M1, Goodarzi Z1, Poortahmasebi V1, Geravand B18, Khamseh A1, Mahmoodi M1, Jazayeri SM1

Hepatitis B surface antigen prevalence in pregnant women: A cross-sectional survey in Iran

Int J Prev Med. 2014 Dec;5(Suppl 3):S213-8

Authors

Shoghli A1, Nabavi SM2, Alavian SM3, Kolifarhood G1, Goya MM4, Namazi R5, Fallahnezhad M6, Mohajeri M7, Mousavinasab N1, Zanjani RS8, Saeini MR9, Jalilvand A10

Clearance of HBV DNA in immunized children born to HBsAg-positive mothers, years after being diagnosed with occult HBV infection

J Viral Hepat. 2016 Apr;23(4):282-5

Authors

Sadeghi A1, Yahyapour Y2, Poortahmasebi V1, Shahmoradi S1, Roggendorf M3, Karimzadeh H3, Alavian SM4, Jazayeri SM1

Appropriate Genotyping of Hepatitis B Virus in Iran

Jundishapur J Microbiol. 2015 Oct 17;8(10):e23529

Authors

Jazayeri SM1, Sharafi H2, Alavian SM2

Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease

Hepat Mon. 2015 Oct 10;15(10):e31434

Authors

^{Shamsoddini A1, Sobhani V1, Ghamar Chehreh ME2, Alavian SM2, Zaree A3}

Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article

Hepat Mon. 2015 Oct 10;15(10):e27063

Authors

Soleimanpour H1, Safari S2, Rahmani F3, Nejabatian A4, Alavian SM5

FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection

Hepat Mon. 2015 Oct 10;15(10):e26490

Authors

Mohammadi A1, Tajik N1, Shah-Hosseini A1, Alavian SM2, Sharifi Z3, Jarahi L4

Low Carbohydrate Rather Than Low Fat Is More Important in Dietary Management of Nonalcoholic Steatohepatitis

Gastroenterology. 2015 Oct 26. pii: S0016-5085(15)01437-7. doi: 10.1053/j.gastro.2015.09.044

Authors

Lankarani KB, Alavian SM

Strategies to manage hepatitis C virus infection disease burden – volume 3

 J Viral Hepat. ۲۰۱۵ Dec;22 Suppl 4:42-65. doi: 10.1111/jvh.12474

Authors

Alfaleh FZ, Nugrahini N, Matičič M, Tolmane I, Alzaabi M, Hajarizadeh B, Valantinas J, Kim DY, Hunyady B, Abaalkhail F, Abbas Z, Abdou A, Abourached A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alashgar HI, Alavian SM, Alawadhi S, Al-Dabal L,Aldins P, Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Andrea N, Assiri AM, Babatin MA, Baqir A, Barakat MT,Bergmann OM, Bizri AR, Chaudhry A, Choi MS, Diab T, Djauzi S, El Hassan ES, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Gheorghe L, Goldis A, Gottfredsson M, Gregorcic S, Gunter J, Hamid S, Han KH, Hasan I, Hashim A, Horvath G, Husni R, Jafri W, Jeruma A, Jonasson JG, Karlsdottir B, Kim YS, Koutoubi Z, Lesmana LA, Liakina V, Lim YS, Löve A, Maimets M, Makara M, Malekzadeh R, Memon MS, Merat S, Mokhbat JE, Mourad FH, Muljono DH, Nawaz A, Olafsson S, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M, Saeed K,Salamat A, Salupere R, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Schmelzer JD, Sharara AI, Sibley A, Siddiq M, Siddiqui AM, Sigmundsdottir G,Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tanaka J, Tarifi H, Tayyab G, Ud Din M, Umar M, Videčnik-Zorman J, Yaghi C, Yunihastuti E,Yusuf MA, Zuberi BF, Blach S

The present and future disease burden of hepatitis C virus infections with today’s treatment paradigm – volume 3

J Viral Hepat. ۲۰۱۵ Dec;22 Suppl 4:21-41. doi: 10.1111/jvh.12476

Authors

Sibley A, Han KH, Abourached A, Lesmana LA, Makara M, Jafri W, Salupere R, Assiri AM, Goldis A, Abaalkhail F, Abbas Z, Abdou A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alavian SM, Alashgar HI, Alawadhi S, Al-Dabal L, Aldins P, Alfaleh FZ,Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Alzaabi M, Andrea N, Babatin MA, Baqir A, Barakat MT, Bergmann OM,Bizri AR, Blach S, Chaudhry A, Choi MS, Diab T, Djauzi S, El Hassan ES, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A,Gheorghe L, Gottfredsson M, Gregorcic S, Gunter J, Hajarizadeh B, Hamid S, Hasan I, Hashim A, Horvath G, Hunyady B, Husni R, Jeruma A, Jonasson JG,Karlsdottir B, Kim DY, Kim YS, Koutoubi Z, Liakina V, Lim YS, Löve A, Maimets M, Malekzadeh R, Matičič M, Memon MS, Merat S, Mokhbat JE, Mourad FH,Muljono DH, Nawaz A, Nugrahini N, Olafsson S, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M,Saeed K, Salamat A, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Sharara AI, Siddiq M, Siddiqui AM, Sigmundsdottir G, Sigurdardottir B, Speiciene D,Sulaiman A, Sultan MA, Taha M, Tanaka J, Tarifi H, Tayyab G, Tolmane I, Ud Din M, Umar M, Valantinas J, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Schmelzer JD

Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 3

J Viral Hepat. 2015 Dec;22 Suppl 4:4-20. doi: 10.1111/jvh.12475

Authors

Liakina V, Hamid S, Tanaka J, Olafsson S, Sharara AI, Alavian SM, Gheorghe L, El Hassan ES, Abaalkhail F, Abbas Z, Abdou A, Abourached A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alashgar HI, Alawadhi S, Al-Dabal L, Aldins P, Alfaleh FZ,Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Alzaabi M, Andrea N, Assiri AM, Babatin MA, Baqir A, Barakat MT,Bergmann OM, Bizri AR, Blach S, Chaudhry A, Choi MS, Diab T, Djauzi S, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Goldis A, Gottfredsson M, Gregorcic S, Hajarizadeh B, Han KH, Hasan I, Hashim A, Horvath G, Hunyady B, Husni R, Jafri W, Jeruma A, Jonasson JG,Karlsdottir B, Kim DY, Kim YS, Koutoubi Z, Lesmana LA, Lim YS, Löve A, Maimets M, Makara M, Malekzadeh R, Matičič M, Memon MS, Merat S, Mokhbat JE,Mourad FH, Muljono DH, Nawaz A, Nugrahini N, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M,Saeed K, Salamat A, Salupere R, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Schmelzer JD, Sibley A, Siddiq M, Siddiqui AM, Sigmundsdottir G,Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tarifi H, Tayyab G, Tolmane I, Ud Din M, Umar M, Valantinas J, Videčnik-Zorman J, Yaghi C,Yunihastuti E, Yusuf MA, Zuberi BF, Gunter J

Detection of Hepatitis B Virus Covalently Closed Circular DNA in the Plasma of Iranian HBeAg-Negative Patients With Chronic Hepatitis B

Hepat Mon. 2015 Sep 29;15(9):e30790. doi: 10.5812/hepatmon.30790. eCollection 2015

Authors

Tajik Z, Keyvani H, Bokharaei-Salim F, Zolfaghari MR, Fakhim S, Keshvari M, Alavian SM

Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C

Hepat Mon. 2015 Sep 29;15(9):e30780. doi: 10.5812/hepatmon.30780. eCollection 2015

Authors

Pouresmaeeli M, Alavian SM, Keshvari M, Salimi S, Mehrnoush L

Anti-Hepatitis E Antibody in Hemodialysis Patients in Isfahan, Iran: Prevalence and Risk Factors

Hepat Mon. 2015 Sep 8;15(9):e23633. doi: 10.5812/hepatmon.23633. eCollection 2015

Authors

Alavian SM, Ataei B, Ebrahimi A, Pirhaji O, Azad R, Olya B, Ataei AM

Hepatitis Delta Virus endorses the selection of Hepatitis B Virus mutants in vivo and functionally impacts their replicative capacity in vitro

Clin Microbiol Infect. 2015 Oct 29. pii: S1198-743X(15)00877-0. doi: 10.1016/j.cmi.2015.09.020

Authors

ََShirvani-Dastgerdi E, Pourkarim MR, Herbers U, Amini-Bavil-Olyaee S, Yagmur E, Alavian SM, Trautwein C, Tacke F.

Impact of the IL-10 Promoter Gene Polymorphisms in the Severity of Chronic Hepatitis B Infection

Hepat Mon. 2015 Jul 22;15(7):e28287. doi: 10.5812/hepatmon.28287v2. eCollection 2015

Authors

Ghaleh Baghi S, Alavian SM, Mehrnoush L, Salimi S

Prevalence of blood-borne viruses among Iranian dentists: Results of a national survey

Int J Occup Med Environ Health. 2015;28(3):593-602. doi: 10.13075/ijomeh.1896.00324

Authors

Ahmad Akhoundi MS, Momeni N, Norouzi M, Ghalichi L, Shamshiri AR, Alavian SM, Poortahmasebi V, Jazayeri SM

High Response Rate to Pegylated Interferon Alpha and Ribavirin Combination Therapy in Hemophilic Children with Chronic Hepatitis C; A Case-Control Study

Pediatr Hematol Oncol. 2015 Sep;32(6):399-405. doi: 10.3109/08880018.2015.1022915. Epub 2015 Jun 18

Authors

Mehrnoush L, Alavian SM, Sharafi H, Behnava B, Salimi S, Keshvari M

The Economic Burden of Liver Cirrhosis in Iran: a Cost of Illness Study

Iran J Public Health. 2015 Apr;44(4):512-21

Authors

Akbari Sari A, Kazemi Karyani A, Alavian SM, Arab M, Rostami Gholmohamadi F, Rezaei S

Efficacy of tenofovir disoproxil fumarate therapy in nucleoside-analogue naive Iranian patients treated for chronic hepatitis B

Hepat Mon. 2015 May 23;15(5):e25749. doi: 10.5812/hepatmon.15(5)2015.25749. eCollection 2015

Authors

Bakhshizadeh F, Hekmat S, Keshvari M, Alavian SM, Mostafavi E, Keivani H, Doosti-Irani A, Motevalli F, Behnava B

Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study

Hepat Mon. 2015 Apr 25;15(5):e23618

Authors

Rezaee R1, Aghcheli B2, Poortahmasebi V2, Qorbani M3, Alavian SM4, Jazayeri SM2

Economic burden of hepatitis B virus-related diseases: evidence from iran

Hepat Mon. 2015 Apr 25;15(4):e25854

Authors

Keshavarz K1, Kebriaeezadeh A2, Alavian SM3, Akbari Sari A4, Abedin Dorkoosh F2, Keshvari M5, Malekhosseini SA6, Nikeghbalian S6, Nikfar S2

Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients

Jundishapur J Microbiol. 2015 Jan 14;8(3):e21444

Authors

Keshvari M1, Alavian SM2, Sharafi H2

Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran

J Med Virol. 2015 Sep;87(9):1565-72

Authors

Samimi-Rad K1, Sadeghi F1, Amirzargar A2, Eshraghian MR3, Alavian SM4, Rahimnia R5

Hepatitis C genotypes distribution in intravenous drug users in tehran

Jundishapur J Microbiol. 2015 Jan 14;8(3):e17134

Author

Alavian SM1

Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013

Transfus Apher Sci. 2015 Aug;53(1):38-47

Authors

Keshvari M1, Sharafi H2, Alavian SM2, Mehrabadi H3, Zolfaghari S4

Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?

Diagn Microbiol Infect Dis. 2015 Jun;82(2):114-9

Authors

Sali S1, Sharafi H2, Alavian SH3, Alavian SM2, Etesam F4, Salimi S2, Merza MA5, Keshvari M6

Sequencing and Phylogenetic Study of Partial NS3 Gene of Iranian GB Virus C/Hepatitis G Virus (HGV) Originated From Hemodialysis Patients in Tehran

Hepat Mon. 2015 Mar 5;15(3):e24173

Authors

Dadmanesh M1, Ranjbar MM2, Alavian SM3, Ghorban K2

Cross-Cultural Adaptation and Psychometric Assessment of the Liver Disease Symptom Index 2.0 to Measure Health-Related Quality of Life Among Iranian Patients With Chronic Hepatitis B

J Transcult Nurs. 2015 Mar 23. pii: 1043659615577698. [Epub ahead of print]

Authors

Saffari M1, Alavian SM2, Naderi MK2, Pakpour AH3, Al Zaben F4, Koenig HG5

Intravenous hypnotic regimens in patients with liver disease; a review article

Anesth Pain Med. 2015 Feb 24;5(1):e23923

Authors

Soleimanpour H1, Safari S2, Rahmani F3, Jafari Rouhi A4, Alavian SM5

Liver biopsy versus non-invasive tests in determining liver disease status

Iran J Radiol. 2015 Jan 18;12(1):e17078

Author

Alavian SM1

The role of inhalational anesthetic drugs in patients with hepatic dysfunction: a review article

Anesth Pain Med. 2015 Jan 7;5(1):e23409

Authors

Soleimanpour H1, Safari S2, Rahmani F3, Ameli H4, Alavian SM5

Nucleic Acid-based approaches for detection of viral hepatitis

Jundishapur J Microbiol. 2014 Dec 10;8(1):e17449

Authors

Behzadi P1, Ranjbar R1, Alavian SM2

School nutrition program; prevention of obesity and Fatty liver in children

Iran J Pediatr. 2014 Aug;24(4):337-8. Epub 2014 Jun 29

Autors

Ardalan G1, Alavian SM2

Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1

Hepat Mon. 2015 Jan 1;15(1):e24955

Autors

Sharafi H1, Alavian SM1, Keshvari M2

Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy

Hepat Mon. 2015 Jan 13;15(1):e23564

Authors

Sandoughdaran S1, Alavian SM2, Sharafi H2, Behnava B2, Salimi S2, Mehrnoush L2, Karimi Elizee P3, Keshvari M4

HBV vaccination status and response to hepatitis B vaccine among Iranian dentists, correlation with risk factors and preventive measures

Hepat Mon. 2014 Dec 27;15(1):e20014

Authors

Momeni N1, Ahmad Akhoundi MS2, Alavian SM3, Shamshiri AR4, Norouzi M5, Mahboobi N1, Moosavi N1, Jazayeri SM5

Oral conditions might cause severe outcomes in patients with viral hepatitis infection

Hepat Mon. 2014 Dec 25;14(12):e25866

Authors

Mahboobi N1, Alavian SM2

Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma

Hepat Mon. 2014 Dec 28;14(12):e25792

Authors

Firouznia K1, Ghanaati H1, Alavian SM2, Azadeh P3, Nasiri Toosi M4, Haj Mirzaian A1, Najafi S5, Shakiba M1, Jalali AH1

Management of liver hemangioma using trans-catheter arterial embolization

Hepat Mon. 2014 Dec 25;14(12):e25788

Authors

Firouznia K1, Ghanaati H1, Alavian SM2, Nassiri Toosi M3, Ebrahimi Daryani N3, Jalali AH1, Shakiba M1, Hosseinverdi S1

Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy

Iran J Basic Med Sci. 2014 Sep;17(9):638-45

Authors

Daram M1, Montazeri G2, Karimzadeh H1, Malekzadeh R2, Mahmoodi M3, Goodarzi Z1, Keyvani H4, Mirmomen S5, Alavian SM6, Roggendorf M7, Jazayeri SM1

A diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: an artificial neural network approach

Med J Islam Repub Iran. 2014 Oct 21;28:116. eCollection 2014

Authors

Pournik O1, Dorri S2, Zabolinezhad H3, Alavian SM4, Eslami S5

Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression

Clin Microbiol Infect. 2015 May;21(5):510.e11-23

Authors

Shirvani-Dastgerdi E1, Amini-Bavil-Olyaee S2, Alavian SM3, Trautwein C1, Tacke F1

Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study

J Clin Diagn Res. 2014 Dec;8(12):HC16-9

Authors

Abbasinazari M1, Alavian SM2, Behnava B3, Asgharinia M4, Salimi S3, Keshvari M3, Mehrnoush L3, Karim P5

Epidemiological history and genomic characterization of non-D1 HBV strains identified in Iran

J Clin Virol. 2015 Feb;63:38-41

Authors

Pineda-Peña AC1, Faria NR2, Mina T3, Amini-Bavil-Olyaee S4, Alavian SM5, Lemey P3, Maes P3, Van Ranst M3, Pourkarim MR6

Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?

Hepat Mon. 2014 Nov 23;14(11):e25540

Authors

Pourhoseingholi MA1, Ashtari S1, Alavian SM2

Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis

Hepat Mon. 2014 Nov 1;14(11):e23235

Authors

Ramezani-Binabaj M1, Motalebi M2, Karimi-Sari H3, Rezaee-Zavareh MS1, Alavian SM4

Hepatotoxicity of halogenated inhalational anesthetics

Iran Red Crescent Med J. 2014 Sep 5;16(9):e20153

Authors

Safari S1, Motavaf M2, Seyed Siamdoust SA1, Alavian SM3

Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization

Transfus Med. 2014 Dec;24(6):411-7

Authors

Keshvari M1, Alavian SM, Aghaee B, Behnava B, Mahdavi M, Fesharaki MG, Sharafi H

Targeting microRNA-122: walking on cutting edge of hepatitis C virus infection therapy

Acta Virol. 2014;58(4):301-8

Authors

Motavaf M, Safari S, Alavian SM

The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations

Hepat Mon. 2014 Oct 11;14(10):e23539

Authors

Imani F1, Motavaf M2, Safari S1, Alavian SM3

The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study

Hepat Mon. 2014 Oct 1;14(10):e22649

Authors

Sharafi H1, Alavian SM2, Behnava B2, Pouryasin A3, Keshvari M4

Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice

Hepat Mon. 2014 Oct 15;14(10):e22215

Authors

Pishraft Sabet L1, Taheri T2, Memarnejadian A3, Mokhtari Azad T4, Asgari F4, Rahimnia R5, Alavian SM6, Rafati S2, Samimi Rad K4

Differentiation of hepatitis B/hepatitis D coinfection and superinfection in asymptomatic blood donors: is it possible?

APMIS. 2014 Oct;122(10):1042

Authors

Keshvari M, Alavian SM, Sharafi H

Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96

Arch Virol. 2015 Jan;160(1):141-52

Authors

Pishraft-Sabet L1, Kosinska AD, Rafati S, Bolhassani A, Taheri T, Memarnejadian A, Alavian SM, Roggendorf M, Samimi-Rad K

Occult hepatitis C virus infection in patients with autoimmune hepatitis

Hepat Mon. 2014 Aug 10;14(8):e16089

Authors

Rezaee Zavareh MS1, Alavian SM2, Karimisari H3, Shafiei M2, Saiedi Hosseini SY2

Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-۲a/RBV combination therapy in Azerbaijani patients

Arch Virol. 2014 Nov;159(11):2893-9

Authors

Bokharaei-Salim F1, Keyvani H, Salehi-Vaziri M, Sadeghi F, Monavari SH, Mehrnoush L, Alavian SM

Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area

J Med Virol. 2014 Nov;86(11):1861-7

Authors

Chenari M1, Norouzi M, Ghalichi L, Rezaee A, Yari A, Alavian SM, Jazayeri SM

Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients

Transfus Med. 2014 Aug;24(4):227-32

Authors

Keshvari M1, Hajibeigi B, Azarkeivan A, Keyvani H, Behnava B, Saiedi Hosseini SY, Sharafi H, Alavian SM

Hepatitis C virus; its implication for endodontists

Iran Endod J. 2014 Summer;9(3):169-73. Epub 2014 Jul 5

Authors

Mahboobi N1, Mahboobi N2, Oliaei P3, Alavian SM4

Anesthesia for patients with liver disease

Hepat Mon. 2014 Jul 1;14(7):e19881

Authors

Rahimzadeh P1, Safari S2, Faiz SH1, Alavian SM3

Interleukin 18 gene promoter polymorphisms and susceptibility to chronic hepatitis B infection: a review study

Hepat Mon. 2014 Jul 1;14(7):e19879

Authors

Motavaf M1, Safari S2, Alavian SM3

Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial

Nutrition. 2014 Jul-Aug;30(7-8):814-21

Authors

Kani AH1, Alavian SM2, Esmaillzadeh A1, Adibi P3, Azadbakht L4

Volatile anesthetics in ischemic liver injury: enemy or friend?

Hepat Mon. 2014 Jun 1;14(6):e19880

Authors

Mohseni M1, Safari S2, Alavian SM3

Predicting the outcomes of combination therapy in patients with chronic hepatitis C using artificial neural network

Hepat Mon. 2014 Jun 1;14(6):e17028

Authors

Sargolzaee Aval F1, Behnaz N1, Raoufy MR2, Alavian SM3

Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection

Asian Pac J Cancer Prev. 2014;15(9):3879-84

Authors

Poortahmasebi V1, Alavian SM, Keyvani H, Norouzi M, Mahmoodi M, Jazayeri SM

Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-۲a and ribavirin in Iranian patients with chronic hepatitis C

J Med Virol. 2014 Sep;86(9):1499-506

Authors

Sadeghi F1, Bokharaei-Salim F, Salehi-Vaziri M, Monavari SH, Alavian SM, Salimi S, Vahabpour R, Keyvani H

Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment

J Formos Med Assoc. 2015 Feb;114(2):195-6

Authors

Sharafi H1, Alavian SM2, Keshvari M3

Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection

Hepat Mon. 2014 May 1;14(5):e17537

Authors

Farzi H1, Ebrahimi Daryani N1, Mehrnoush L2, Salimi S2, Alavian SM2

Classical and modern approaches used for viral hepatitis diagnosis

Hepat Mon. 2014 Apr 16;14(4):e17632

Authors

Heiat M1, Ranjbar R1, Alavian SM2

Protective Effect of Cornus mas Fruits Extract on Serum Biomarkers in CCl4-Induced Hepatotoxicity in Male Rats

Hepat Mon. 2014 Apr 14;14(4):e10330

Authors

Alavian SM1, Banihabib N2, Es Haghi M3, Panahi F4

Comment on “No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance” by Ubaldo Visco-Comandini et al. [Dig. Liver Dis. 2014;46:348-52]

Dig Liver Dis. 2014 Aug;46(8):761-2

Authors

Keshvari M1, Sharafi H2, Alavian SM3

Distinct Toll-like Receptor 3 and 7 Expression in Peripheral Blood Mononuclear Cells From Patients with Chronic Hepatitis C Infection

Hepat Mon. 2014 Apr 7;14(4):e16421

Authors

Motavaf M1, Noorbakhsh F2, Alavian SM3, Sharifi Z4

Interferon alpha-2b therapy in chronic hepatitis delta

Hepat Mon. 2014 Mar 1;14(3):e15729

Authors

Keshvari M1, Alavian SM2, Sharafi H2, Karimi G3, Gholami Fesharaki M4

Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance- A Meta-Analysis

Hepat Mon. 2014 Mar 2;14(3):e15895

Authors

Aalaei-Andabili SH1, Behnava B2, Salimi S2, Sharafi H2, Alavian SM3

Comments on behavior of healthcare workers after injuries from sharp instruments

Trauma Mon. 2014 Feb;19(1):e17040

Author

Alavian SM1

An unbelievable fact on “dialysis centers without hepatitis C infection”

Nephrourol Mon. 2014 Mar 1;6(2):e17998

Author

Alavian SM1

Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran

Oman Med J. 2014 Mar;29(2):92-6

Authors

Anvari FA1, Alavian SM2, Norouzi M1, Mahabadi M2, Jazayeri SM1

Vaccination in Health Care Workers Should be Following in our Country Now?!

Iran Red Crescent Med J. 2013 Dec;15(12):e17145

Author

Alavian SM1

Non-viral related liver enzymes elevation after kidney transplantation

Hepat Mon. 2014 Feb 5;14(2):e9036

Authors

Einollahi B1, Ghadian A1, Ghamar-Chehreh E2, Alavian SM3

How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level?

Hepat Mon. 2014 Feb 5;14(2):e15285

Authors

Keshvari M1, Alavian SM2, Sharafi H2

Diet macronutrients composition in nonalcoholic Fatty liver disease: a review on the related documents

Hepat Mon. 2014 Feb 17;14(2):e10939

Authors

Hashemi Kani A1, Alavian SM2, Haghighatdoost F1, Azadbakht L1

How can the IL28B polymorphisms with linkage disequilibrium affect the natural course of hepatitis B inversely?

Liver Int. 2014 Aug;34(7):1127

Authors

Keshvari M1, Alavian SM, Sharafi H

Prevalence of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population

Asian Pac J Cancer Prev. 2014;15(2):1065

Authors

Alavian SM1, Jazayeri SM.

Molecular characterization of hepatitis B virus (HBV) strains circulating in the northern coast of the Persian Gulf and its comparison with worldwide distribution of HBV subgenotype D1

J Med Virol. 2014 May;86(5):745-57

Authors

Pourkarim MR1, Vergote V, Amini-Bavil-Olyaee S, Sharifi Z, Sijmons S, Lemey P, Maes P, Alavian SM, Van Ranst M

What is the ethnicity-specific impact of genetic polymorphisms on the response to hepatitis C treatment in an admixed population of Brazilian patients?

Clinics (Sao Paulo). 2014 Feb;69(2):152

Authors

Keshvari M1, Alavian SM2, Sharafi H2

Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies

Hepat Mon. 2014 Jan 3;14(1):e15167

Authors

Pournik O1, Alavian SM2, Ghalichi L3, Seifizarei B4, Mehrnoush L5, Aslani A6, Anjarani S7, Eslami S8

GB Virus C/Hepatitis G Virus Envelope Glycoprotein E2: Computational Molecular Features and Immunoinformatics Study

Hepat Mon. 2013 Dec 30;13(12):e15342

Authors

Ranjbar MM1, Ghorban K2, Alavian SM3, Keyvani H4, Dadmanesh M5, Roayaei Ardakany A6, Motedayen MH7, Sazmand A8

Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran

Hepat Mon. 2013 Dec 16;13(12):e14324

Authors

Mousavi SF1, Moosavy SH1, Alavian SM2, Eghbali H1, Mahboobi H3

Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C

Aliment Pharmacol Ther. 2014 Feb;39(3):343

Authors

Keshvari M1, Pouryasin A, Behnava B, Sharafi H, Hajarizadeh B, Alavian SM

Can we include genetic variants with high linkage disequilibrium into a multiple logistic model?

Liver Int. 2014 Jul;34(6):964

Authors

Keshvari M1, Sharafi H, Hajarizadeh B, Alavian SM

Lessons learned from past cholera epidemics, interventions which are needed today

J Res Med Sci. 2013 Aug;18(8):630-1.

Authors

Lankarani KB1, Alavian SM2

Sofosbuvir has come out of the magic box

Hepat Mon. 2013 Dec 16;13(12):e16916

Author

Alavian SM1

Impact of Pegylated Interferon-alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study

Hepat Mon. 2013 Nov 23;13(11):e11903

Authors

Mahdavi M1, Amirrasouli H1, Alavian SM2, Behnava B3, Kazerouni F1, Keshvari M4, Namaki S1, Gholami Fesharaki M5, Rahimipour H6, Mohammadzade J1, Zohrehbandian F7, Mahdavipour F8

The role of celiac disease in severity of liver disorders and effect of a gluten free diet on diseases improvement

Hepat Mon. 2013 Oct 13;13(10):e11893

Authors

Rostami-Nejad M1, Haldane T2, Aldulaimi D2, Alavian SM3, Zali MR1, Rostami K4

Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein

Acta Virol. 2013;57(4):389-96

Authors

Motavaf M, Safari S, Saffari Jourshari M, Alavian SM

Distribution of hepatitis C virus genotypes among azerbaijani patients in capital city of iran-tehran

Hepat Mon. 2013 Sep 1;13(9):e13699

Authors

Bokharaei-Salim F1, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Nasseri S

Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in iran

Hepat Mon. 2013 Sep 1;13(9):e10236

Authors

Mehrazmay A1, Alavian SM, Moradi-Lakeh M, Mokhtari Payam M, Hashemi-Meshkini A, Behnava B, Miri SM, Karimi Elizee P, Tabatabaee SV, Keshvari M, Bagheri Lankarani K

Understanding of molecular pain medicine: genetic basis of variation in pain sensation and analgesia response

Anesth Pain Med. 2013 Winter;2(3):104-6

Authors

Motavaf M1, Safari S, Alavian SM

Oral conditions associated with hepatitis C virus infection

Saudi J Gastroenterol. 2013 Nov-Dec;19(6):245-51

Authors

Alavian SM1, Mahboobi N, Mahboobi N, Karayiannis P

Application of zero-inflated poisson mixed models in prognostic factors of hepatitis C

Biomed Res Int. 2013;2013:403151

Authors

Akbarzadeh Baghban A1, Pourhoseingholi A, Zayeri F, Jafari AA, Alavian SM

Evolutionary analysis of HBV “S” antigen genetic diversity in Iranian blood donors: a nationwide study

J Med Virol. 2014 Jan;86(1):144-55

Authors

Pourkarim MR1, Sharifi Z, Soleimani A, Amini-Bavil-Olyaee S, Elsadek Fakhr A, Sijmons S, Vercauteren J, Karimi G, Lemey P, Maes P, Alavian SM, Van Ranst M

Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference?

Hepat Mon. 2013 Aug 12;13(8):e11138

Authors

Abbasinazari M1, Behnava B, Panahi Y, Hajhossein Talasaz A, Salimi S, Keshvari M, Mehrnoush L, Karim Elizee P, Gholami Fesharaki M, Asgharinia M, Alavian SM

Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical pictures

Hepat Mon. 2013 Aug 16;13(8):e6731

Authors

Ghamari S1, Alavian SM, Rizzetto M, Olivero A, Smedile A, Khedive A, Alavian SE, Zolfaghari MR, Jazayeri SM

Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis

Hepat Mon. 2013 Aug 5;13(8):e11290

Authors

Keyvani H1, Bokharaei-Salim F, Monavari SH, Esghaei M, Nassiri Toosi M, Fakhim S, Sadigh ZA, Alavian SM

Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users

Hepat Mon. 2013 Aug 17;13(8):e12411

Authors

Alavian SM1, Mirahmadizadeh A, Javanbakht M, Keshtkaran A, Heidari A, Mashayekhi A, Salimi S, Hadian M

Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up

Hepat Mon. 2013 Jul 8;13(7):e8743

Authors

Sali S1, Alavian SM, Foster GR, Keyvani H, Mehrnoosh L, Mohammadi N

HBV Subgenotypes D1, D2, D-del! Are ‘Old’ Genotyping Methods Interpreted Correctly?

Hepat Mon. 2013 Jul 1;13(7):e13048

Authors

Amini-Bavil-Olyaee S1, Tacke F, Alavian SM

Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD)

Hepat Mon. 2013 Jul 13;13(7):e10943

Authors

Hashemi Kani A1, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L

Prevention of hepatitis a virus infection, need to vaccinate or not?

Int J Prev Med. 2013 Aug;4(8):863-5

Authors

Elizee PK1, Alavian SM

Mutational analysis of HBs Ag-positive mothers and their infected children despite immunoprophylaxis

Iran J Allergy Asthma Immunol. 2013 Aug 28;12(4):352-60

Authors

Ghaziasadi A1, Alavian SM, Norouzi M, Fazeli Z, Jazayeri SM

Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran

Hepat Mon. 2013 May 29;13(5):e10134

Authors

Vakili Ghartavol Z1, Alavian SM, Amini S, Vahabpour R, Bahramali G, Mostafavi E, Aghasadeghi MR

Direct medical care costs associated with patients diagnosed with chronic HCV

Hepat Mon. 2013 Apr 28;13(5):e8415

Authors

Ashtari S1, Vahedi M, Pourhoseingholi MA, Karkhane M, Kimiia Z, Pourhoseingholi A, Safaee A, Moghimi-Dehkordi B, Zali MR, Alavian SM

Lower intrafamilial transmission rate of hepatitis B in patients with hepatitis d coinfection: a data-mining approach

Hepat Mon. 2013 May 23;13(5):e7652

Authors

Pournik O1, Alavian SM, Ghalichi L, Hajibeigi B, Razavi AR, Eslami S

Estimation of diagnosis and treatment costs of non-alcoholic Fatty liver disease: a two-year observation

Hepat Mon. 2013 May 8;13(5):e7382

Authors

Ghamar Chehreh ME1, Vahedi M, Pourhoseingholi MA, Ashtari S, Khedmat H, Amin M, Zali MR, Alavian SM

Hepatitis delta: the rediscovery

Clin Liver Dis. 2013 Aug;17(3):475-87

Authors

Rizzetto M1, Alavian SM

Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis

J Res Med Sci. 2012 Oct;17(10):967-74

Authors

Alavian SM1, Tabatabaei SV, Behnava B, Rizzetto M

Hepatitis B virus surface antigen (HBsAg) mutations are rare but clustered in immune epitopes in chronic carriers from Sistan-Balouchestan Province, Iran

Arch Iran Med. 2013 Jul;16(7):385-9

Authors

Khedive A1, Sanei-Moghaddam I, Alavian SM, Saberfar E, Norouzi M, Judaki M, Ghamari S, Jazayeri SM

Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study

J Viral Hepat. 2013 Jul;20(7):494-501

Authors

Khedive A1, Norouzi M, Ramezani F, Karimzadeh H, Alavian SM, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Judaki MA, Ghamari S, Daram M, Mahabadi M, Fazeli Z, Goodarzi Z, Poortahmasebi V, Jazayeri SM

Collecting blood just from voluntary repeated blood donors is the wisdom strategy in Vietnam

Indian J Med Res. 2013 Apr;137(4):813

Author

Alavian SM

Evaluation of Knowledge and Practice of Hairdressers in Women’s Beauty Salons in Isfahan About Hepatitis B, Hepatitis C, and AIDS in 2010 and 2011

Hepat Mon. 2013 Mar 6;13(3):e6215

Authors

Ataei B1, Shirani K, Alavian SM, Ataie M

Hepatitis B virus infection: need for more attention in hemodialysis patients

Saudi J Kidney Dis Transpl. 2013 May;24(3):587-8

Authors

Einollahi B, Alavian SM

Probiotic as a novel treatment strategy against liver disease

Hepat Mon. 2013 Feb 25;13(2):e7521

Authors

Imani Fooladi AA1, Mahmoodzadeh Hosseini H, Nourani MR, Khani S, Alavian SM

Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients

Hepat Mon. 2013 Jan 20;13(1):e6712

Authors

Mahabadi M1, Norouzi M, Alavian SM, Samimirad K, Azad TM, Saberfar E, Mahmoodi M, Ramezani F, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Hossein Somi M, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Ali Judaki M, Ghamari S, Daram M, Fazeli Z, Goodarzi Z, Khedive A, Moradi A, Jazayeri SM

Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains

Hepat Mon. 2013 Jan 23;13(1):e7699

Authors

Samimi-Rad K1, Asgari F, Nasiritoosi M, Esteghamati A, Azarkeyvan A, Eslami SM, Zamani F, Magnius L, Alavian SM, Norder H

Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis

Hepat Mon. 2013 Jan;13(1):e8210

Authors

Amini N1, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M

Distribution of hepatitis C virus genotypes in Iranian chronic infected patients

Hepat Mon. 2013 Jan;13(1):e7991

Authors

Jahanbakhsh Sefidi F1, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F

Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals

Hepat Mon. 2012 Dec;12(12):e8387

Authors

Sharafi H1, Pouryasin A, Alavian SM, Behnava B, Keshvari M, Salimi S, Mehrnoush L, Fatemi A

Dental treatment as a risk factor for hepatitis B and C viral infection. A review of the recent literature

J Gastrointestin Liver Dis. 2013 Mar;22(1):79-86

Authors

Mahboobi N1, Porter SR, Karayiannis P, Alavian SM

Intra-familial Transmission of Hepatitis B virus Infection in Zahedan

Iran Red Crescent Med J. 2013 Jan;15(1):4-8

Authors

Hatami H1, Salehi M, Sanei E, Khosravi S, Alavian SM

Health in the Islamic Republic of Iran, challenges and progresses

Med J Islam Repub Iran. 2013 Feb;27(1):42-9

Authors

Lankarani KB1, Alavian SM, Peymani P

Psychometric Properties of a Standardized Questionnaire of Knowledge, Attitude, and Practice of Iranian Medical Specialists about Viral Hepatitis

Hepat Mon. 2012 Dec;12(12):e7650

Authors

Ghasemi S1, Kabir A, Ansari Jafari M, Jalali M, Amini A, Faghihi-Kashani AH, Alavian SM

Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence

Iran J Radiol. 2012 Nov;9(4):167-77

Authors

Ghanaati H1, Alavian SM, Jafarian A, Ebrahimi Daryani N, Nassiri-Toosi M, Jalali AH, Shakiba M

Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study

Ann Hepatol. 2013 Mar-Apr;12(2):213-9

Authors

Keyvani H1, Agah S, Kabir A, Alavian SM

Can we accurately assess liver fibrosis with Fibroscan® using fewer valid measurements?

Yonsei Med J. 2013 Mar 1;54(2):541-2

Authors

Pournik O, Alavian SM, Eslami S

Efficacy of influenza vaccination in patients with cirrhosis and inactive carriers of hepatitis B virus infection

Iran Red Crescent Med J. 2012 Oct;14(10):623-30. Epub 2012 Oct 30

Authors

Sayyad B1, Alavian SM, Najafi F, Mokhtari Azad T, Ari Tabarestani MH, Shirvani M, Behnava B, Afshrian M, Vaziri S, Janbakhsh AR, Mansouri F, Kaviani Sh

Random effect model for identifying related factors to virological response in HCV patients

Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S65-9

Authors

Zayeri F1, Chaibakhsh S2, Pourhoseingholi A2, Baghban AA3, Alavian SM4

Statistical count models for prognosis the risk factors of hepatitis C

Gastroenterol Hepatol Bed Bench. 2013 Winter;6(1):41-7

Authors

Pourhoseingholi A1, Baghban AA2, Zayeri F3, Alavian SM4, Vahedi M5

Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study

Int J Prev Med. 2012 Nov;3(11):770-5

Authors

Alavian SM1, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, Abolghasemi H

Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran

Iran J Public Health. 2012;41(3):104-11. Epub 2012 Mar 31

Authors

Norouzi M1, Ghorashi S, Abedi F, Nejatizadeh A, Ataei B, Malekzadeh R, Alavian S, Judaki M, Ghamari S, Namazi A, Rahimnia R, Khedive A, Jazayeri S

Celiac disease and abnormal liver function test

Int J Prev Med. 2012 Oct;3(10):745-6

Authors

Rostami Nejad M1, Alavian SM

High Rate of Virological Response to Peginterferon α-۲a-Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C

Iran Red Crescent Med J. 2012 Aug;14(8):466-9. Epub 2012 Aug 30

Authors

Alavi Moghaddam M1, Zali MR, Aalaei Andabili SH, Derakhshan F, Miri SM, Alavian SM

Letter to the editor: the increasing hepatitis a incidence in Korea: is it possible within a limited time?

J Prev Med Public Health. 2012 Sep;45(5):329-30; author reply 331-2

Authors

Elizee PK, Alavian SM, Miri SM

Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in HIV/ AIDS Patients: A Randomized Controlled Trial

Hepat Mon. 2012 Sep;12(9):e6234

Authors

Sayad B1, Alavian SM, Najafi F, Soltani B, Shirvani M, Janbakhsh A, Mansouri F, Afsharian M, Vaziri S, Alikhani A, Bashiri H

Real response to therapy in chronic hepatitis C virus patients: a study from iran

Hepat Mon. 2012 Sep;12(9):e6151

Authors

Namazee N1, Sali S, Asadi S, Shafiei M, Behnava B, Alavian SM

Occult Hepatitis B (OBH) in Clinical Settings

Hepat Mon. 2012 Aug;12(8):e6126

Authors

Alavian SM1, Miri SM, Hollinger FB, Jazayeri SM

Principles of meta-analysis should be well understood

Obes Surg. 2012 Dec;22(12):1926-7

Authors

Aalaei-Andabili SH, Alavian SM

Persistence of anti-HBs antibody in children whom vaccinated during infantile period and need to booster needs more discussion

Eur J Pediatr. 2013 Jun;172(6):855

Author

Alavian SM

Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C

J Viral Hepat. 2012 Nov;19(11):757-65

Authors

Motavaf M1, Safari S, Alavian SM

Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature

Transpl Infect Dis. 2012 Oct;14(5):445-51

Authors

Mahboobi N1, Tabatabaei SV, Blum HE, Alavian SM

HCV genotypes distribution pattern in India

Indian J Med Res. 2012 Aug;136(2):306-7; author reply 307-8

Authors

Bokharaei-Salim F, Alavian SM

Seronegative anti-hepatitis C virus antibody in hemodialysis patients

Hemodial Int. 2013 Apr;17(2):328

Author

Alavian SM

Important steps for a reliable meta-analysis

Lancet Infect Dis. 2012 Sep;12(9):663

Authors

Aalaei-Andabili SH, Alavian SM

Occult hepatitis B in thalassemia: a need for further study

J Infect Dev Ctries. 2012 Aug 21;6(8):650-1

Author

Alavian SM

On the occasion of the world hepatitis day: world hepatitis day and our achievements and responsibilities in iran

Int J Prev Med. 2012 Jul;3(7):437-9

Author

Alavian SM1

Hepatitis B virus and HIV coinfections can be interpreted in different ways

J Infect Chemother. 2013 Feb;19(1):183

Author

Alavian SM

Liver Hemangioma Might Lead to overestimation of Liver Fibrosis by Fibroscan; A Missed Issue in Two Cases

Hepat Mon. 2012 Jun;12(6):408-10

Aythors

Aalaei-Andabili SH1, Mehrnoush L, Salimi S, Shafiei M, Alavian SM

Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy

Hepat Mon. 2012 Jun;12(6):372-81

Authors

Tabatabaei SV1, Alavian SM, Keshvari M, Behnava B, Miri SM, Karimi Elizee P, Zamani F, Amini Kafiabad S, Gharehbaghian A, Hajibeigy B, Lankarani KB

Risk factors of viral hepatitis: yet to explore

Transfus Apher Sci. 2012 Oct;47(2):145-9

Authors

Bozorgi SH1, Ramezani H, Nooranipour M, Ahmadi M, Baghernejad A, Mostajeri A, Kargar-Fard H, Sadri M, Alavian SM

Seroepidemiology of HBV infection in South-East of iran; a population based study

Iran Red Crescent Med J. 2012 May;14(5):283-8. Epub 2012 May 30

Authors

Salehi M1, Alavian SM, Tabatabaei SV, Izadi Sh, Sanei Moghaddam E, Amini Kafi-Abad S, Gharehbaghian A, Khosravi S, Abolghasemi H

Inauspicious contribution of hepatitis C virus and diabetes mellitus targeting kidneys: an update

Iran J Kidney Dis. 2012 Jul;6(4):236-54

Authors

Alavian SM1, Taheri S

HBsAg variants: diagnostic-escape and diagnostic dilemma

J Clin Virol. 2013 Jul;57(3):201-8

Authors

Alavian SM1, Carman WF, Jazayeri SM

Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran

Hepat Mon. 2012 May;12(5):339-43

Authors

Zahedi MJ1, Darvish Moghaddam S, Alavian SM, Dalili M

Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis

Vaccine. 2012 Aug 17;30(38):5595-602

Authors

Aalaei-Andabili SH1, Alavian SM

HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article

Iran Red Crescent Med J. 2011 Dec;13(12):855-62. Epub 2011 Dec 1

Authors

Ranjbar R1, Davari A, Izadi M, Jonaidi N, Alavian SM

Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time

Arch Virol. 2012 Oct;157(10):1959-65. Epub 2012 Jun 13

Authors

Samimi-Rad K1, Nasiri Toosi M, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, Shabestari AN, Hassanpour G, Alavian SM, Asgari F

Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis

Hepat Mon. 2012 Apr;12(4):244-52

Authors

Alavian SM1, Aalaei-Andabili SH

Occult hepatitis B virus infection among hemodialysis patients

Hepat Mon. 2012 Apr;12(4):242-3

Author

Alavian SM1

Hepatitis B vaccine: prophylactic, therapeutic, and diagnostic dilemma

Minerva Gastroenterol Dietol. 2012 Jun;58(2):167-78

Authors

Alavian SM1, Miri SM, Jazayeri SM

High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG

J Hepatol. 2012 Sep;57(3):515-21

Authors

Shahmoradi S1, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM

The prevalence of hepatitis B virus surface antigen (HBsAg) variations and correlation with the clinical and serologic pictures in chronic carriers from Khorasan Province, North-East of Iran

Acta Med Iran. 2012;50(4):265-72

Authors

Ghaziasadi A1, Ziaee M, Norouzi M, Malekzadeh R, Alavian SM, Saberfar E, Judaki MA, Ghamari S, Khedive A, Namazi A, Rahimnia R, Jazayeri SM

Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran

East Mediterr Health J. 2012 Mar;18(3):227-35

Authors

Samimi-Rad K1, Hosseini M, Mobeini G, Asgari F, Alavian SM, Tahaei ME, Salari H

Halothane: how should it be used in a developing country?

East Mediterr Health J. 2012 Feb;18(2):159-64

Authors

Mahboobi N1, Esmaeili S, Safari S, Habibollahi P, Dabbagh A, Alavian SM

Prevalence of hepatitis d virus infection among hepatitis B virus infected patients in qom province, center of iran

Hepat Mon. 2012 Mar;12(3):205-8

Authors

Ghadir MR1, Belbasi M, Heidari A, Sarkeshikian SS, Kabiri A, Ghanooni AH, Iranikhah A, Vaez-Javadi M, Alavian SM

Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response

Hepat Mon. 2012 Mar;12(3):190-5

Authors

Sharafi H1, Pouryasin A, Alavian SM, Behnava B, Keshvari M, Mehrnoush L, Salimi S, Kheradvar O

Hepatitis B immune globulin in liver transplantation prophylaxis: an update

Hepat Mon. 2012 Mar;12(3):168-76

Authors

Dindoost P1, Jazayeri SM, Alavian SM

Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran

Hepat Mon. 2012 Feb;12(2):112-7

Authors

Ghadir MR1, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, Kabiri A, Ghanooni AH, Iranikhah A, Alavian SM

Autoimmune hepatitis in Iran: what we know, what we don’t know and requirements for better management

Hepat Mon. 2012 Feb;12(2):73-6

Authors

Shafiei M1, Alavian SM

Should routine screening for celiac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C or not

Bratisl Lek Listy. 2012;113(4):251

Authors

Nejad MR, Alavian SM

Hepatitis B virus variants in HBV mono-infected versus HBV/HIV co-infected patients

Curr HIV Res. 2012 Apr;10(3):245-6

Authors

Jazayeri SM, Alavian SM

Commentary on “risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States”

Am J Gastroenterol. 2012 Apr;107(4):635

Authors

Alavian SM, Jazayeri SM

letter to Hajiani E, Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic Analysis of Hepatitis C Virus in Khuzestan Province, Southwestern Iran. Middle East J Dig Dis 2011;3:126-30

Middle East J Dig Dis. 2012 Apr;4(2):133-4

Authors

Alavian SM1, Bagheri Ankarani K2

High-quality meta-analyses are required for development of evidence in medicine

J Infect Dis. 2012 May 1;205(9):1472; author reply 1473

Authors

Aalaei-Andabili SH, Alavian SM

Intravenous drug use and hepatitis C virus in iran

Hepat Mon. 2012 Jan;12(1):9-10

Authors

Zobeiri M1, Adibi P, Alavian SM

RNA interference: a promising approach for the treatment of viral hepatitis

Hepat Mon. 2012 Jan;12(1):7-8

Authors

Motavaf M1, Alavian SM

Correlation of Hepatitis B surface antigen mutations with clinical status of the chronically infected patients from Kermanshah, West of Iran

Minerva Gastroenterol Dietol. 2012 Mar;58(1):9-18

Authors

Sayad B1, Anvari FA, Alavian SM, Norouzi M, Hamzelooie M, Shirvani M, Pourhoseingholi A, Khedive A, Ghamari S, Judaki MA, Jazayeri SM

Transmission of HBV infection from mothers HBsAg positive to infants need to more attention

J Clin Virol. 2012 Jun;54(2):201

 Author

Alavian SM

Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis

Hepat Mon. 2011 Dec;11(12):960-7

Authors

Amini N1, Alavian SM, Kabir A, Saiedi Hosseini SY, Aalaei Andabili SH

IL28B polymorphism, Explanation for Different Responses to Therapy in Hepatitis C Patients

Hepat Mon. 2011 Dec;11(12):958-9

Authors

Sharafi H1, Alavian SM

Herbal medicine and liver disease, for any conclusion we need to do more studies

J Res Med Sci. 2011 Jul;16(7):974-5

Author

Alavian SM1

Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta-analysis

J Viral Hepat. 2012 Feb;19(2):88-93

Authors

Alavian SM1, Tabatabaei SV, Behnava B

Using statistical models to assess medical cost of hepatitis C virus

Gastroenterol Hepatol Bed Bench. 2012 Winter;5(Suppl 1):S31-6

Authors

Vahedi M1, Pourhoseingholi A2, Ashtari S3, Pourhoseingholi MA2, Karkhane M3, Moghimi-Dehkordi B3, Safaee A3, Kimia Z3, Alavian SM4

One swallow doesn’t bring spring, reply to Khamesipour et al

Transfus Apher Sci. 2012 Feb;46(1):103

Author

Alavian SM

Oral fluid and hepatitis A, B and C: a literature review

J Oral Pathol Med. 2012 Aug;41(7):505-16

Author

Mahboobi N1, Porter SR, Karayiannis P, Alavian SM

Iranian dental students’ knowledge of hepatitis B virus infection and its control practices

J Dent Educ. 2011 Dec;75(12):1627-34

Authors

Alavian SM1, Mahboobi N, Mahboobi N, Savadrudbari MM, Azar PS, Daneshvar S

Seroprevalence of hepatitis B and C infection markers among children and adolescents in the southern Brazilian region

Rev Inst Med Trop Sao Paulo. 2011 Nov-Dec;53(6):347

Author

Alavian SM

Optimal duration of treatment for HCV genotype 1 infection in slow responders: a meta-analysis

Hepat Mon. 2011 Aug;11(8):612-9

Authors

Alavian SM1, Tabatabaei SV, Behnava B, Mahboobi N

Virus-triggered autophagy in viral hepatitis – possible novel strategies for drug development

J Viral Hepat. 2011 Dec;18(12):821-30

Authors

Alavian SM1, Ande SR, Coombs KM, Yeganeh B, Davoodpour P, Hashemi M, Los M, Ghavami S

Re: Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana’a, Yemen-We need to work much harder to control hepatitis B virus infection in developing countries

Sultan Qaboos Univ Med J. 2011 Nov;11(4):529-30. Epub 2011 Oct 25

Author

Alavian SM1

Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings

Hepat Mon. 2011 Jun;11(6):452-8

Authors

Khosravi S1, Alavian SM, Zare A, Daryani NE, Fereshtehnejad SM, Daryani NE, Keramati MR, Abdollahzade S, Taba Taba Vakili S

IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report

Hepat Mon. 2011 May;11(5):386-8

Authors

Mahboobi N1, Behnava B, Alavian SM

Liver complications in celiac disease

Hepat Mon. 2011 May;11(5):333-41

Authors

Zali MR1, Rostami Nejad M, Rostami K, Alavian SM

The impact of Hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies: The impact of HCV on renal transplantation

Hepat Mon. 2011 Apr;11(4):247-54

Authors

Rostami Z1, Nourbala MH, Alavian SM, Bieraghdar F, Jahani Y, Einollahi B

Anti-HBs antibody status and some of its associated factors in dental health care workers in Tehran University of Medical Sciences: Anti-HBs Ab and associated factors in dental society

Hepat Mon. 2011 Feb;11(2):99-102

Authors

Alavian SM1, Mahboobi N, Mahboobi N

Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV

Hepat Mon. 2011 Feb;11(2):67-8

Authors

Alavian SM1, Miri SM

Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis

Hepat Mon. 2011 Jan;11(1):3-6

Authors

Habibollahi P1, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Alavian SM

Successful exclusion of blood-borne viral disease in blood donors

Eur J Intern Med. 2011 Dec;22(6):e71-4

Authors

Ramezani H1, Bozorgi SH, Nooranipour M, Sadri M, Molaverdikhani S, Alavian SM

Confidential unit exclusion and blood safety

Sao Paulo Med J. 2011;129(5):359-60

Author

Alavian SM

HBeAg negativity is not equal to the presence of pre core mutations in chronic hepatitis B patients

Saudi Med J. 2011 Nov;32(11):1206; author reply 1206-7

Authors

Jazayeri SM, Alavian SM

Hepatitis B vaccination in hemodialysis patients: different points of view for conclusion

J Bras Nefrol. 2011 Jul-Sep;33(3):389-90; author reply 391

Author

Alavian SM

The impact of HBV vaccination on Brazilian adolescents requires more attention

Cad Saude Publica. 2011 Oct;27(10):2070

Authors

Alavian SM, Aalaei-Andabili SH

Accelerated vaccination against HBV infection is an important strategy for the control of HBV infection in prisons

Rev Soc Bras Med Trop. 2011 Oct;44(5):652; author reply 653.

Author

Alavian SM

Commentary on: Treatment of HCV infection in chronic kidney disease

Nefrologia. 2011;31(5):607; author reply 607-8

Author

Alavian SM

New globally faces of hepatitis B and C in the world

Gastroenterol Hepatol Bed Bench. 2011 Fall;4(4):171-4

Author

Alavian SM1

Hepatitis a in developed country, the result should interpret carefully

Gut Liver. 2011 Sep;5(3):395-6

Author

Alavian SM1

Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic Patients

Gut Liver. 2011 Sep;5(3):348-55

Authors

Alavian SM1, Miri SM, Tabatabaei SV, Keshvari M, Behnava B, Elizee PK, Mahboobi N, Lankarani KB.

Other views of occult hepatitis B in Hepatitis C infected patients

Eur J Intern Med. 2011 Oct;22(5):e67-8

Authors

Alavian SM, Jazayeri SM

Epidemiology of Hepatitis B virus infection and the main risk factors in Pakistan needs more attention

Saudi J Gastroenterol. 2011 Sep-Oct;17(5):369-70

Author

Alavian SM

Commentary on emergence of hepatitis B virus S gene mutants in patients experiencing HBsAg seroconversion after peginterferon therapy

Hepatology. 2011 Nov;54(5):1889; author reply 1889-90

Authors

Jazayeri SM, Alavian SM

YMDD motif mutation after lamivudine therapy

Asian J Transfus Sci. 2011 Jul;5(2):178-9

Authors

Jazayeri SM1, Miri SM, Alavian SM

Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-α among naïve chronic hepatitis B patients?

Vaccine. 2011 Nov 8;29(48):9093-7

Authors

Alavi-Moghaddam M1, Alavian SM, Aalaei-Andabili SH, Eslami-Far A

Education by a nurse increases the adherence to therapy in chronic hepatitis C patients

Clin Gastroenterol Hepatol. 2012 Feb;10(2):203; author reply 203

Authors

Alavian SM, Aalaei-Andabili SH

More risk factors of hepatitis C transmission should be considered in Pakistan

Int J Prev Med. 2011 Jul;2(3):188-9

Authors

Alavian SM, Aalaei-Andabili SH

Hepatitis B infection in dentistry setting needs more attention

Med Princ Pract. 2011;20(5):491-2

Authors

Alavian SM, Mahboobi N.

Hepatitis A

Aust Fam Physician. 2011 Apr;40(4):185

Author

Alavian SM

Epidemiology of hepatitis C in the Middle East: all available data

Saudi J Kidney Dis Transpl. 2011 Jul;22(4):808-9

Authors

Alavian SM, Saiedi SY, Alaei SH

Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence

PLoS One. 2011;6(6):e21178

Authors

Poustchi H1, George J, Esmaili S, Esna-Ashari F, Ardalan G, Sepanlou SG, Alavian SM

Hepatitis B genotypes distribution in South Asia and Middle East

Infect Genet Evol. 2011 Aug;11(6):1193-4

Authors

Jazayeri SM, Miri SM, Alavian SM

Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease

J Med Virol. 2011 Jun;83(6):989-95

Authors

Bokharaei-Salim F1, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, Mohammad Alizadeh AH

Risk factors of hepatitis B infection: Health policy makers should be aware of their importance in each community

Hepat Mon. 2011 Apr 1;11(4):238-9

Authors

Miri SM1, Alavian SM

Occult hepatitis B in high-risk patients needs more attention

J Infect Dev Ctries. 2011 Mar 2;5(2):149-50

Authors

Alavian SM

Prevalence and risk factors of hepatitis A among blood donors in Qazvin, central Iran

Singapore Med J. 2011 Feb;52(2):107-12

Authors

Ramezani H1, Bozorgi SH, Nooranipour M, Mostajeri A, Kargar-Fard H, Molaverdikhani S, Mazdaki A, Alavian SM

A nationwide survey of prevalence of pediculosis in children and adolescents in iran

Iran Red Crescent Med J. 2011 Mar;13(3):167-70. Epub 2011 Mar 1

Authors

Amirkhani MA1, Alavian SM, Maesoumi H, Aminaie T, Dashti M, Ardalan G, Ziaoddini H, Mirmoghtadaee P, Poursafa P, Kelishadi R

Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination

Health Policy. 2011 May;100(2-3):297-304

Authors

Asli AA1, Moghadami M, Zamiri N, Tolide-Ei HR, Heydari ST, Alavian SM, Lankarani KB

Immune response to hepatitis B vaccine in health-care workers

Saudi J Kidney Dis Transpl. 2011 Jan;22(1):179-84

Authors

Zamani F1, Fallahian F, Hashemi F, Shamsaei Z, Alavian SM

Intrafamily transmission of HCV need to more discussion

Iran Red Crescent Med J. 2011 Jan;13(1):64. Epub 2011 Jan 1

Author

Alavian SM1

Comment on: Epidemiology of Hepatitis B Virus Infection in Hamadan, West of Iran

J Res Health Sci. 2011 Nov 4;11(2):121-3

Authors

Kabir A1, Alavian SM

Elevated prevalence of hepatitis B in Mexican hemodialysis patients. A multicentric survey

Arch Med Res. 2010 Oct;41(7):576; author reply 577

Authors

Alavian SM

WITHDRAWN: Low dose ribavirin for treatment of HCV infected thalassemia major patients: New indications for combination therapy

J Hepatol. 2010 Nov 23. [Epub ahead of print]

Authors

Tabatabaei SV1, Alavian SM, Keshvari M, Behnava B, Miri SM, Elizee PK, Zamani F, Kafi-Abad SA, Gharehbaghian A, Hajibeigy B, Lankarani KB